$HRTX, Heron Therapeutics Inc (HRTX) Moves Hig
Post# of 22756
(Total Views: 135)
Posted On: 02/26/2017 9:43:48 PM
$HRTX,
Heron Therapeutics Inc (HRTX) Moves Higher on Volume Spike for February 24
Equities Staff | Friday, 24 February 2017 17:18 (EST)
Market Summary
Heron Therapeutics Inc is a A biotechnology company
Last Price
$ 13.90
Last Trade
Feb/24 - 16:00
Change
$ 0.15
Change Percent
1.09 %
Open
$ 14.30
Prev Close
$ 13.75
High
$ 14.75
low
$ 13.80
52 Week High
$ 25.46
52 Week Low
$ 12.21
Market Cap
744,686,023
PE Ratio
42.12
Volume
1,649,416
Exchange
NSC
HRTX - Market Data & News
HRTX - Stock Valuation Report
Heron Therapeutics Inc (HRTX) traded on unusually high volume on Feb. 24, as the stock gained 1.09% to close at $13.90. On the day, Heron Therapeutics Inc saw 1.65 million shares trade hands on 8,724 trades. Considering that the stock averages only a daily volume of 914,529 shares a day over the last month, this represents a pretty significant bump in volume over the norm.
Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.
The stock has traded between $25.46 and $12.21 over the last 52-weeks, its 50-day SMA is now $13.39, and its 200-day SMA $16.74. Heron Therapeutics Inc has a P/B ratio of 39.71.
Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
Headquartered in Redwood City, CA, Heron Therapeutics Inc has 148 employees and is currently under the leadership of CEO Barry D. Quart.
For a complete fundamental analysis analysis of Heron Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for HRTX.
Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.
To get more information on Heron Therapeutics Inc and to follow the company’s latest updates, you can visit the company’s profile page here: HRTX’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
Heron Therapeutics Inc (HRTX) Moves Higher on Volume Spike for February 24
Equities Staff | Friday, 24 February 2017 17:18 (EST)
Market Summary
Heron Therapeutics Inc is a A biotechnology company
Last Price
$ 13.90
Last Trade
Feb/24 - 16:00
Change
$ 0.15
Change Percent
1.09 %
Open
$ 14.30
Prev Close
$ 13.75
High
$ 14.75
low
$ 13.80
52 Week High
$ 25.46
52 Week Low
$ 12.21
Market Cap
744,686,023
PE Ratio
42.12
Volume
1,649,416
Exchange
NSC
HRTX - Market Data & News
HRTX - Stock Valuation Report
Heron Therapeutics Inc (HRTX) traded on unusually high volume on Feb. 24, as the stock gained 1.09% to close at $13.90. On the day, Heron Therapeutics Inc saw 1.65 million shares trade hands on 8,724 trades. Considering that the stock averages only a daily volume of 914,529 shares a day over the last month, this represents a pretty significant bump in volume over the norm.
Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.
The stock has traded between $25.46 and $12.21 over the last 52-weeks, its 50-day SMA is now $13.39, and its 200-day SMA $16.74. Heron Therapeutics Inc has a P/B ratio of 39.71.
Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.
Headquartered in Redwood City, CA, Heron Therapeutics Inc has 148 employees and is currently under the leadership of CEO Barry D. Quart.
For a complete fundamental analysis analysis of Heron Therapeutics Inc, check out Equities.com’s Stock Valuation Analysis report for HRTX.
Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.
To get more information on Heron Therapeutics Inc and to follow the company’s latest updates, you can visit the company’s profile page here: HRTX’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
Scroll down for more posts ▼